Atlas Trials

Ropivacaine 0,2% Plus Dexamethasone Versus Ropivacaine 0,2% Plus Placebo in Modified Pectoral Block

Clinical trial NCT03700177 · UNKNOWN

Trial details

NCT number
NCT03700177
Sponsor
Medical University Innsbruck
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Effect of DrugsBreast PainAnesthesia, Local
Start date
2019-02-01
Primary completion
2020-12-31
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.